The global pharmaceutical market is about $781 billion as of 2014, of which 23 percent, or $179 billion, comes from biologic drugs, more than double the $82.5 billion memory chip market.
The market for contract manufacturing of biologics is expected to surge to $7.2 billion by 2017 from $4.6 billion five years ago.
No comments:
Post a Comment